Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

Hard-to-treat cancers: What makes them special?

How can we accelerate drug discovery and development for patients with hard-to-treat cancers?

Date

12 Sep 2022

Session

Hard-to-treat cancers: What makes them special?

Topics

Clinical Research;  Pathology/Molecular Biology;  Targeted Therapy

Tumour Site

Presenters

Elena Garralda

Authors

E. Garralda

Author affiliations

  • Early Drug Development Group, Vall d'Hebron University Hospital, 8035 - Barcelona/ES

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Discussion

Presenter: All Speakers

Session: Hard-to-treat cancers: What makes them special?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.